These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 6650958)

  • 41. Warfarin pharmacokinetics in the horse.
    Thijssen HH; van den Bogaard AE; Wetzel JM; Maes JH; Muller AP
    Am J Vet Res; 1983 Jul; 44(7):1192-6. PubMed ID: 6881659
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetics of ticarcillin in the horse after intravenous and intramuscular administration.
    Sweeney CR; Soma LR; Beech J; Reef V; Simmons R
    Am J Vet Res; 1984 May; 45(5):1000-2. PubMed ID: 6732002
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serum and tissue fluid norfloxacin concentrations after oral administration of the drug to healthy dogs.
    Walker RD; Stein GE; Budsberg SC; Rosser EJ; MacDonald KH
    Am J Vet Res; 1989 Jan; 50(1):154-7. PubMed ID: 2919820
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The intramuscular bioavailability of a phenylbutazone preparation in the horse.
    Landuyt J; Delbeke FT; Debackere M
    J Vet Pharmacol Ther; 1993 Dec; 16(4):494-500. PubMed ID: 8126767
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetics of phenylbutazone in two age groups of ponies: a preliminary study.
    Lees P; Maitho TE; Taylor JB
    Vet Rec; 1985 Mar; 116(9):229-32. PubMed ID: 4002593
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetics and tissue fluid distribution of cephalexin in the horse after oral and i.v. administration.
    Davis JL; Salmon JH; Papich MG
    J Vet Pharmacol Ther; 2005 Oct; 28(5):425-31. PubMed ID: 16207304
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phenylbutazone and its metabolites in plasma and urine of thoroughbred horses: population distributions and effects of urinary pH.
    Houston T; Chay S; Woods WE; Combs G; Kamerling S; Blake JW; Edmundson AG; Vessiney R; Tobin T
    J Vet Pharmacol Ther; 1985 Jun; 8(2):136-49. PubMed ID: 4020945
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effectiveness of administration of phenylbutazone alone or concurrent administration of phenylbutazone and flunixin meglumine to alleviate lameness in horses.
    Keegan KG; Messer NT; Reed SK; Wilson DA; Kramer J
    Am J Vet Res; 2008 Feb; 69(2):167-73. PubMed ID: 18241011
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Phenylbutazone blood and urine concentrations, pharmacokinetics, and effects on biomarkers of inflammation in horses following intravenous and oral administration of clinical doses.
    Knych HK; Arthur RM; McKemie DS; Seminoff K; Hamamoto-Hardman B; Kass PH
    Drug Test Anal; 2019 Jun; 11(6):792-803. PubMed ID: 30499176
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Plasma and synovial fluid kinetics, disposition, and urinary excretion of naproxen in horses.
    Soma LR; Uboh CE; Rudy JA; Perkowski SZ
    Am J Vet Res; 1995 Aug; 56(8):1075-80. PubMed ID: 8533980
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Drug interactions in the horse: effects of chloramphenicol, quinidine, and oxyphenbutazone on phenylbutazone metabolism.
    Tobin T; Blake JW; Valentine R
    Am J Vet Res; 1977 Jan; 38(1):123-7. PubMed ID: 835859
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of the pharmacokinetics and bioavailability of intravenously and orally administered amiodarone in horses.
    De Clercq D; Baert K; Croubels S; van Loon G; Maes A; Tavernier R; Deprez P; De Backer P
    Am J Vet Res; 2006 Mar; 67(3):448-54. PubMed ID: 16506906
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacokinetic and pharmacodynamic studies on phenylbutazone and oxyphenbutazone in goats.
    Cheng Z; Welsh E; Nolan A; McKellar QA
    Vet Rec; 1997 Jan; 140(2):40-3. PubMed ID: 9123796
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacokinetics and body fluid and endometrial concentrations of cephapirin in mares.
    Brown MP; Gronwall RR; Houston AE
    Am J Vet Res; 1986 Apr; 47(4):784-8. PubMed ID: 3963579
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Kinetic analysis of D-xylose distribution after intravenous administration to mares.
    Ferrante PL; Freeman DE; Ramberg CF; Kronfeld DS
    Am J Vet Res; 1993 Jan; 54(1):147-51. PubMed ID: 8427459
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phenylbutazone and oxyphenbutazone distribution into tissue fluids in the horse.
    Lees P; Taylor JB; Higgins AJ; Sharma SC
    J Vet Pharmacol Ther; 1986 Jun; 9(2):204-12. PubMed ID: 3723663
    [TBL] [Abstract][Full Text] [Related]  

  • 57. NTP technical report on the toxicity studies of p-tert-butylcatechol (CAS No. 98-29-3) administered in feed to F344/N rats and B6C3F1 mice.
    Dunnick J
    Toxic Rep Ser; 2002 Nov; (70):5-51. PubMed ID: 12592414
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacokinetics of phenylbutazone in camels.
    Wasfi IA; Abdel Hadi AH; Zorob O; Osman M al-G ; Boni NS
    Am J Vet Res; 1997 Jun; 58(6):636-40. PubMed ID: 9185972
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Chronopharmacokinetics of phenylbutazone in the horse. Application to antidoping control].
    Jaussaud P; Courtot D; Doron P; Guyot JL
    Ann Rech Vet; 1985; 16(4):385-91. PubMed ID: 4091494
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Single- and repeat-dose pharmacokinetic studies of chloramphenicol in horses: values and limitations of pharmacokinetic studies in predicting dosage regimens.
    Varma KJ; Powers TE; Powers JD
    Am J Vet Res; 1987 Mar; 48(3):403-6. PubMed ID: 3565895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.